PMS37 RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE

David Kaplan; Benjamin S.‐Y. Ung; Corey Pelletier; Chuka Udeze; M. Tian

doi:10.1016/j.jval.2019.04.1147

RDLNetworkEkosistem

Hakkımızda SSS

Giriş yap Başla

Hakkımızda SSS Gizlilik Şartlar İletişim

PMS37 RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE — David Kaplan (2019) | RDL Network

Back

Home
Publications
PMS37 RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE

Shared by

David Kaplan

PMS37 RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE

Article 2019 en

Authors

DK
David Kaplan
BU
Benjamin S.‐Y. Ung
CP
Corey Pelletier

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.jval.2019.04.1147
Year: 2019
Published: —
Language: en

Article Details

Volume: 22
Link Of The Paper: https://doi.org/10.1016/j.jval.2019.04.1147

Timeline

Created:June 19, 2026

Related publications

Article2019

PSS15 REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

David Kaplan, Benjamin S.‐Y. Ung, C. Udeze, C. Pelletier, M. Tian

Article2019

PSS6 COMPARISON OF TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE

David Kaplan, Benjamin S.‐Y. Ung, Corey Pelletier, Chuka Udeze, M. Tian

Article2019

SAT0400 REAL-WORLD SWITCH RATES AMONG BIOLOGIC-NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST, TUMOR NECROSIS FACTOR INHIBITORS OR INTERLEUKIN INHIBITORS

David Kaplan, Brian Ung, Corey Pelletier, Chuka Udeze, Marc Tian

Article2019

PSS14 REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

David Kaplan, Benjamin S.‐Y. Ung, Corey Pelletier, Chuka Udeze, M. Tian

Article2021

Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis

David Kaplan, Brian Ung, Corey Pelletier, Chuka Udeze, Ibrahim Khilfeh, Marc Tian